Rapid & Transparent Publishing

Fast publication and open peer review for research stemming from horizon 2020, Horizon Europe and Euratom funding across all subject areas.
 

Rapid & Transparent Publishing

Open Research Europe is an open access publishing platform for the publication of research stemming from Horizon 2020, Horizon Europe and/or Euratom funding across all subject areas. The platform makes it easy for Horizon 2020, Horizon Europe and Euratom beneficiaries to comply with the open access terms of their funding and offers researchers a publishing venue to share their results and insights rapidly and facilitate open, constructive research discussion.
 
 

Benefits for Research

  • Rapid open access publication enables others to build upon new ideas right away, wherever and whoever they are. 
  • Removes obstacles to collaborative research through data sharing, transparency and attribution.
  • Shifts the way research and researchers are evaluated by supporting research assessment based on the intrinsic value of the research rather than the venue of publication.
 

Benefits for Researchers

  • Optional service with no author fees, no administrative burden and automatic compliance with open access requirements.
  • Submissions published rapidly as preprints after a set of thorough prepublication checks.
  • Transparent peer-review: authors suggest appropriate reviewers and engage in an open and public dialogue with their peers.
 

Benefits for Society

  • Maximises the value and impact of Horizon 2020, Horizon Europe and Euratom projects byenabling publication of all aspects of Commission funded research.
  • Makes research results fully open access, freely available and fully text and data minable for researchers as well as citizens.
  • Accelerates the progress of research meaning new insights, innovations and treatments become available to those who need them more rapidly. 
COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi